App-Quantinova.ai

First case of Diabetes Mellitus Caused by compound heterozygous changes in the WFS1 and PTF1A Genes from Kazakhstan

Dariga Aralbayeva - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Diabetes

Metformin Hydrochloride

Ketoacidosis and Age Distribution in New-Onset Type 1 Diabetes During Covid-19 Pandemic

Maja Vinkovic - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Autoimmune Thyroid Disease

N/A

Atypical diabetes with spontaneous remission associated with systemic lupus erythematosus in an adolescent girl with African ancestry

Fanny Luterbacher - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Lupus

Mycophenolate mofetil

Diabetes Secondary to Glucokinase Gene Polymorphism with Obesity and Fluctuating Severity of Diabetes

Sarraa Aljalily - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acanthosis Nigricans

Gemfibrozil

Effect of carbohydrate counting education in Korean patients with type 1 diabetes.

Hae In Lee - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Prandial Insulin

A Novel Mutation in the Hepatocyte Nuclear Factor 1-Alpha Detected in Case of a 13-Year-Old Female with Maturity Onset Diabetes of the Young (MODY)

Ja Hyang Cho - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Maturity onset diabetes of the young

sulfonylureas

Recurrent glycogenic hepatopathy in an 11-year-old boy with poor glycemic controlled type 1 diabetes mellitus

Daiki Sasaoka - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Low vitamin D levels are associated with markers of metabolic syndrome in children with newly onset type 1 diabetes mellitus

Elsa Puerto-Carranza - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Ergocalciferol

Rituximab Role in Preservation of Pancreatic Beta Cells in Patients Newly Diagnosed With Type 1 Diabetes Mellitus: A Report of 2 Palestinian Cases.

Hasan Eida - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Rituximab

100 years with insulin. Implementation of analogs and technology in our environment

Ignacio Diez-Lopez - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Syncope

Liraglutide

Contribution of 25 Hydroxy Vitamin D to the Risk of Development of Type 1 Diabetes in Children

Asmae Touzani - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

Ergocalciferol

Liraglutide associated with a multidisciplinary program for the treatment of adolescents obesity in a low income setting: a real life experience

Mariana Griffero - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dyslipidemia

Liraglutide

Gender differences in Italian pediatric obese subjects

Elena Inzaghi - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Prediabetes in Obesity Adolescents: Frequency, Structure, Relationship with Body Mass Index

Nadezda Minkova - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Prediabetes

N/A

Leptin receptor deficiency: a case report

Yulduz Zufarova - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypogonadotropic hypogonadism

Metformin Hydrochloride

Hypoglycemia as a result of growth hormone deficiency and Glycogen storage disease type 0a in a patient with short stature – case report

Maja Okońska - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Postprandial hyperglycemia

hGH

Poor efficacy of growth hormone treatment in a patient with fetal alcohol syndrome

Nobuhiko Koga - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Substance Abuse

Alcohol Dependence

hGH

Glucose dysregulation and Diabetes mellitus in ROHHAD syndrome - possibly centrally driven?

Katherine Hawton - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Neurohypophyseal diabetes insipidus

hGH

Prader Willi Syndrome with Cribiform Papillary Thyroid Carcinoma. A case to share

Carina López Avellaneda - European Society for Paediatric Endocrinology (ESPE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Familial adenomatous polyposis

Levothyroxine

HbA1C AND OUTCOMES IN PATIENTS WITH CKD STAGE 3b AND 4

Z.K. Tan - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

N/A

Filters

4759 Abstracts